Table 2.
In silico inhibition constant (Ki) obtained by molecular docking for the top 10 drugs.
S. no. | Ligands | In silico inhibition constant in (Ki) value in Molar |
---|---|---|
1. | Lopinavir–Ritonavir | 1.6754 × 10−8 |
2. | Tipranavir | 4.1487 × 10−7 |
3. | Raltegravir | 8.1265 × 10−7 |
4. | Improved-α-ketoamide 13b | 8.1535 × 10−7 |
5. | Nelfinavir | 9.6539 × 10−7 |
6. | Dolutegravir | 1.1230 × 10−6 |
7. | Tenofovir-disoproxil | 1.1430 × 10−6 |
8. | Baloxavir-marboxil | 1.1435 × 10−6 |
9. | Letermovir | 1.3533 × 10−6 |
10. | Maraviroc | 1.3236 × 10−6 |